Serum soluble CD163 levels in patients with influenza-associated encephalopathy

Brain and Development

Volumn 35, Issue 7, 2013, Pages 626-629

  Hasegawa, Shunji ^a   Matsushige, Takeshi ^a   Inoue, Hirofumi ^a   Takahara, Midori ^a   Kajimoto, Madoka ^a   Momonaka, Hiroshi ^a   Ishida, Chiemi ^a   Tanaka, Saya ^a   Morishima, Tsuneo ^b   Ichiyama, Takashi ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

Encephalopathy; Influenza; Macrophages; Monocytes; Soluble CD163

Indexed keywords

CD163 ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; BRAIN DISEASE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOKINE STORM; DISEASE ASSOCIATION; FEMALE; HUMAN; INFANT; INFLUENZA; INFLUENZA ASSOCIATED ENCEPHALOPATHY; MACROPHAGE ACTIVATION; MALE; MONOCYTE; OUTCOME ASSESSMENT; PATHOGENESIS; PRESCHOOL CHILD; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; SCHOOL CHILD;

ADULT; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BIOLOGICAL MARKERS; BRAIN DISEASES; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFANT; INFLUENZA, HUMAN; MACROPHAGE ACTIVATION; MALE; MONOCYTES; PROGNOSIS; RECEPTORS, CELL SURFACE;

EID: 84879462454     PISSN: 03877604     EISSN: 18727131     Source Type: Journal    
DOI: 10.1016/j.braindev.2012.10.005     Document Type: Article

References (9)

1. Ichiyama T., Morishima T., Isumi H., Matsufuji H., Matsubara T., Furukawa S. Analysis of cytokine levels and NF-κB activation in peripheral blood mononuclear cells in influenza virus-associated encephalopathy. Cytokine 2004, 27:31-37.
2. Hasegawa S., Matsushige T., Inoue H., Shirabe K., Fukano R., Ichiyama T. Serum and cerebrospinal fluid cytokine profile of patients with 2009 pandemic H1N1 influenza virus-associated encephalopathy. Cytokine 2011, 54:167-172.
3. Nguyen T.T., Schwartz E.J., West R.B., Warnke R.A., Arber D.A., Natkunam Y. Expression of CD163 (hemoglobin scavenger receptor) in normal tissues, lymphomas, carcinomas, and sarcomas is largely restricted to the monocyte/macrophage lineage. Am J Surg Pathol 2005, 29:617-624.
4. Hintz K.A., Rassias A.J., Wardwell K., Moss M.L., Morganelli P.M., Pioli P.A., et al. Endotoxin induces rapid metalloproteinase-mediated shedding followed by up-regulation of the monocyte hemoglobin scavenger receptor CD163. J Leukoc Biol 2002, 72:711-717.
5. Fabriek B.O., Møller H.J., Vloet R.P., van Winsen L.M., Hanemaaijer R., Teunissen C.E., et al. Proteolytic shedding of the macrophage scavenger receptor CD163 in multiple sclerosis. J Neuroimmunol 2007, 187:179-186.
6. Møller H.J., Moestrup S.K., Weis N., Wejse C., Nielsen H., Pedersen S.S., et al. Macrophage serum markers in pneumococcal bacteremia: prediction of survival by soluble CD163. Crit Care Med 2006, 34:2561-2566.
7. Møller H.J., Grønbaek H., Schiødt F.V., Holland-Fischer P., Schilsky M., Munoz S., et al. Soluble CD163 from activated macrophages predicts mortality in acute liver failure. J Hepatol 2007, 47:671-676.
8. Bleesing J., Prada A., Siegel D.M., Villanueva J., Olson J., Ilowite N.T., et al. The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis. Arthritis Rheum 2007, 56:965-971.
9. Ichiyama T., Morishima T., Kajimoto M., Matsushige T., Matsubara T., Furukawa S. Matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 in influenza-associated encephalopathy. Pediatr Infect Dis J 2007, 26:542-544.